The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer?
dc.contributor.author | Sand, CA | en_US |
dc.contributor.author | Hobbs, AJ | en_US |
dc.date.accessioned | 2017-03-22T11:51:17Z | |
dc.date.available | 2015-10-12 | en_US |
dc.date.issued | 2016-02 | en_US |
dc.date.submitted | 2016-11-28T16:40:36.915Z | |
dc.identifier.issn | 1537-1891 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/22102 | |
dc.format.extent | 35 - 37 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | VASCULAR PHARMACOLOGY | en_US |
dc.title | The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer? | en_US |
dc.type | Article | |
dc.rights.holder | © 2015 Elsevier Inc. | |
dc.identifier.doi | 10.1016/j.vph.2015.10.008 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369776600005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | No embargo | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 77 | en_US |